Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06219161 · ClinicalTrials.gov registry record · NA
The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06219161 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 12 participants.
The verdict
NCT06219161, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal of the study is to determine the acute and short-term supplementation effect of a commercially available theacrine-containing supplement (NAD3) on numbers of various circulating stem cell populations in older adults.
Interventions
- DIETARY_SUPPLEMENT NAD3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-01-02 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06219161
The ClinicalTrials.gov registry entry for NCT06219161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NAD3 is the first listed.
NCT06219161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06219161 about?
NCT06219161 is a clinical study titled "The Acute Effect of a Theacrine-based Supplement on Mobilization of Various Stem Cell Populations.". The goal of the study is to determine the acute and short-term supplementation effect of a commercially available theacrine-containing supplement (NAD3) on numbers of various circulating stem cell populations in older adults.
What is the current status of trial NCT06219161?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2023-01-02. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT06219161?
The interventions under investigation include: NAD3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06219161?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.